Table 2 Quantitative and qualitative CMR measures presented for entire patient cohort and by AF status

n

101

66

35

-

Mean ± SD acquisition time, mins

7:51 ± 2:58

8:14 ± 3:10

7:08 ± 2:25

0.08

Mean ± SD acceptance rate

54.4 ± 11.8%

53.8 ± 12.3%

55.5 ± 10.8%

0.50

Mean ± SD dose of MultiHance (mL)

29.8 ± 8.5

29.0 ± 7.8

31.4 ± 9.7

0.18

Mean ± SD consensus quality score

3.4 ± 0.7

3.4 ± 0.7

3.3 ± 0.7

0.58

Quality, n (%)

0.58^#

 Uninterpretable

1 (1.0%)

0 (0%)

1 (2.9%)

 Poor

9 (8.9%)

8 (12.1%)

1 (2.9%)

 Good

40 (39.6%)

22 (33.3%)

18 (51.4%)

 Excellent

51 (50.5%)

36 (54.6%)

15 (42.8%)